 OSAKA, Japan--BUSINESS WIRE--Takeda Pharmaceutical Company Limited TOKYO:4502NYSE:TAK Takeda today announced financial results for the first quarter of fiscal year 2021 period ended June 30, 2021. Based on the solid first-quarter results, the Company also confirmed its fiscal year 2021 management guidance and forecast. Fiscal year 2021 remains a year of inflection with Takeda positioned for topline acceleration and continued pipeline progress, including critical regulatory submission 